Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.08 USD | +1.31% | +2.69% | -14.14% |
Apr. 10 | North American Morning Briefing : Traders Await -2- | DJ |
Apr. 09 | BMO Capital Upgrades Chemours to Outperform From Underperform, Raises Price Target to $34 From $19 | MT |
Evolution of the average Target Price on The Chemours Company
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering The Chemours Company
BMO Capital | |
UBS | |
RBC Capital Markets | |
Goldman Sachs | |
Morgan Stanley | |
Barclays | |
BofA Securities | |
JPMorgan Chase | |
Credit Suisse | |
Citigroup | |
Argus | |
Alembic Global | |
Wolfe Research | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- CC Stock
- Consensus The Chemours Company